Straumann Holding AG
SIX:STMN
P/B
Price to Book Value
Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.
Market Cap | P/B | ||||
---|---|---|---|---|---|
CH |
Straumann Holding AG
SIX:STMN
|
18.6B CHF | 10.1 | ||
US |
Shockwave Medical Inc
NASDAQ:SWAV
|
215.1B USD | 286.1 | ||
US |
Abbott Laboratories
NYSE:ABT
|
187.1B USD | 4.8 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
148.1B USD | 10.6 | ||
US |
Stryker Corp
NYSE:SYK
|
133.1B USD | 6.9 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
113.4B USD | 5.7 | ||
IE |
Medtronic PLC
NYSE:MDT
|
110.2B USD | 2.2 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
69.9B USD | 2.7 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
61.6B EUR | 3.3 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
53.1B USD | 7.5 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
362.5B CNY | 11 |
P/B Forward Multiples
Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.